Infectious Disease

National Jewish Health was founded in 1899 as a hospital to treat patients with tuberculosis infections. Since our inception, we have made groundbreaking discoveries in infectious disease research. Our physician-scientists were among the leaders in developing combined chemotherapy treatments for fighting tuberculosis. Here is an overview of our infectious disease research programs:

  • Non-Tuberculosis Mycobacterial (NTM) Lung Infection Research: Our research focuses on understanding and treating NTM infections in individuals with bronchiectasis. This research spans genetics, epidemiology, pathogenesis, diagnostics and treatment strategies.
  • Clinical Trials and Studies: Our physician-scientists conduct clinical trials to evaluate new and emerging treatments for pulmonary infections, aiming to improve patient outcomes and develop more effective therapies.
  • Infectious Disease Research Advancements: Developed the culture medium to grow tuberculosis. Combined chemotherapy for tuberculosis. Novel anti-viral lipid therapeutics against COVID and influenza virus.
  • Tyler J. Couch

    Tyler J. Couch, MD

  • Rafael Sobrano Fais

    Rafael Sobrano Fais, PhD

  • Andrew M. Freeman

    Andrew M. Freeman, MD, FACC, FACP

  • Marjorie Patricia George

    Marjorie Patricia George, MD

  • Kristen Glisinski

    Kristen Glisinski, MD

  • Tim Lahm

    Tim Lahm, MD, ATSF

  • Susan M. Majka

    Susan M. Majka, PhD

  • Karina Mora Massad

    Karina Mora Massad, MD

  • Irina Petrache

    Irina Petrache, MD

  • Soonho Yoon

    Soonho Yoon, MD, PhD

Find a Doctor